Drawing for DYMAXIUM

USPTO serial 77833279

DYMAXIUM

Reviewed by CopyMark Law Group

Reg. 4122194Status 710
Filing date
Status date
Registration date
Apr 3, 2012
Examiner
BROWN, BARBARA TROFFKIN
Law office
TMO LAW OFFICE 116

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DYMAXIUM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patrick C. Stephenson

Patrick C. Stephenson Kutak Rock LLP1650 Farnam St.Omaha, NE 68102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; downloadable electronic instructional and marketing publications, namely, published research abstracts, research posters, slides, reports, user manuals, instructional brochures, marketing brochures, handouts, periodicals, newsletters, reprint articles, training guides and tutorials, instructional resource cards, flow charts and diagrams, for use in the healthcare, medical, pharmaceutical and biotechnology fieldsSECTION 8 - CANCELLED—
016Printed instructional and marketing publications, namely, published research abstracts, research posters, slides, reports, user manuals, instructional brochures, marketing brochures, handouts, periodicals, newsletters, reprint articles, training guides and tutorials, instructional resource cards, flow charts and diagrams, for use in the healthcare, medical, pharmaceutical and biotechnology fieldsSECTION 8 - CANCELLED—
035Consulting and research services in the areas of health economics and outcomesSECTION 8 - CANCELLED—
041Non-downloadable electronic instructional and marketing publications, namely, published research abstracts, research posters, slides, reports, user manuals, instructional brochures, marketing brochures, handouts, periodicals, newsletters, reprint articles, training guides and tutorials, instructional resource cards, flow charts and diagrams, for use in the healthcare, medical, pharmaceutical and biotechnology fields; providing web sites that feature non-downloadable electronic instructional and marketing publications, namely, published research abstracts, research posters, slides, reports, user manuals, instructional brochures, marketing brochures, handouts, periodicals, newsletters, reprint articles, training guides and tutorials, instructional resource cards, flow charts and diagrams, for use in the healthcare, medical, pharmaceutical and biotechnology fieldsSECTION 8 - CANCELLED—
042Development of software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; development of non-downloadable web-based software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; providing use of non-downloadable software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; providing use of non-downloadable web-based software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fields; providing non-downloadable web-based software, namely, dossier software for searching, filtering and reviewing information within product dossiers, data analysis and outcome analyzer tool software for analyzing data and outcomes, economic model software for assessing economic outcomes, budget impact and cost-effectiveness of products, and health-related communication and educational software all for asking questions, generating requests, obtaining feedback, sharing best practices and resources and for conducting on-line surveys, all for use in healthcare, medical, pharmaceutical and biotechnology fields; providing technical support services, namely, troubleshooting of computer software problems relating to non-downloadable web-based software, namely, dossier software for searching, filtering and reviewing information within product dossiers, data analysis and outcome analyzer tool software for analyzing data and outcomes, economic model software for assessing economic outcomes, budget impact and cost-effectiveness of products, and health-related communication and educational software all for asking questions, generating requests, obtaining feedback, sharing best practices and resources and for conducting on-line surveys, all to help improve processed focused on clinical, economic, and humanistic outcomes all in the healthcare, medical, pharmaceutical and biotechnology fields; providing information in the biotechnology field to help improve processes focused on clinical, economic, and humanistic outcomes; consulting and research services in the biotechnology fields; non-downloadable web-based software for modeling data, analyzing data, interfacing with databases, presenting data and creating learning tools for understanding data, for use in the healthcare, medical, pharmaceutical and biotechnology fieldsSECTION 8 - CANCELLED—
044Providing information in the healthcare, medical and pharmaceutical fields to help improve processes focused on the clinical, economic and humanistic outcomes; consulting and research services in the pharmaceutical, healthcare and medical fieldsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2022CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Dec 17, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 17, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 3, 2021REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 11, 2020CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Apr 27, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 27, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 27, 2020EWORTEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED—
Apr 27, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 27, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 27, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 9, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 7, 2019ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 11, 2018NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 11, 2018C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 11, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Apr 2, 2018E815TEAS SECTION 8 & 15 RECEIVED—
Apr 3, 2017REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 19, 2015CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 19, 2015COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 16, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 3, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 29, 2012SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 28, 2012REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Feb 21, 2012CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jan 23, 2012SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 23, 2012AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 21, 2011IUAFUSE AMENDMENT FILED—
Dec 21, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 29, 2011EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 27, 2011EX1GSOU EXTENSION 1 GRANTED—
Jun 27, 2011EXT1SOU EXTENSION 1 FILED—
Jun 27, 2011EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 28, 2010NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 2, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 2, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 27, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 27, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Sep 27, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 27, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 27, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 22, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2010ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 27, 2010PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 24, 2010EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Aug 19, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 19, 2010ALIEASSIGNED TO LIE—
Aug 2, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 2, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Aug 2, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 2, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 2, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 1, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 1, 2010CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 9, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 9, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 20, 2009GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2009GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2009DOCKASSIGNED TO EXAMINER—
Sep 28, 2009TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Sep 28, 2009PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 28, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 26, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance